Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
about
Combination therapy for the treatment of pulmonary mold infections.The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials.Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
P2860
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Spotlight on fluticasone furoa ...... velopment and place in therapy
@ast
Spotlight on fluticasone furoa ...... velopment and place in therapy
@en
Spotlight on fluticasone furoa ...... velopment and place in therapy
@nl
type
label
Spotlight on fluticasone furoa ...... velopment and place in therapy
@ast
Spotlight on fluticasone furoa ...... velopment and place in therapy
@en
Spotlight on fluticasone furoa ...... velopment and place in therapy
@nl
prefLabel
Spotlight on fluticasone furoa ...... velopment and place in therapy
@ast
Spotlight on fluticasone furoa ...... velopment and place in therapy
@en
Spotlight on fluticasone furoa ...... velopment and place in therapy
@nl
P2093
P2860
P921
P356
P1476
Spotlight on fluticasone furoa ...... velopment and place in therapy
@en
P2093
Mark Sutter
Michael Schivo
Samuel Bullick
Timothy Albertson
P2860
P304
P356
10.2147/DDDT.S113573
P407
P577
2016-12-14T00:00:00Z